Unavailable
Unavailable
Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
8-K - Catheter Precision, Inc. (0001716621) (Filer)
EFFECT - Catheter Precision, Inc. (0001716621) (Filer)
424B3 - Catheter Precision, Inc. (0001716621) (Filer)
4 - Catheter Precision, Inc. (0001716621) (Issuer)
4 - Catheter Precision, Inc. (0001716621) (Issuer)
4 - Catheter Precision, Inc. (0001716621) (Issuer)
Flyte's Vision Jet Fleet to Be Featured on Blade Platform, Expanding Distribution across One of the Industry's Leading Air Mobility Networks Strategic Partnership Expected to Increase Aircraft Utilization, Customer Acquisition, Brand Awareness, and Platform-Driven Revenue Opportunities Strategic Relationship Further Validates Flyte's Regional Air Mobility Model and Expands Reach into Blade's Ecosystem FORT MILL, S.C., July 21, 2026 (GLOBE NEWSWIRE) -- Fly Flyte, Inc. ("FLYTE"), the Regional Air Mobility subsidiary of Catheter Precision, Inc. (NYSE:VTAK), today announced a strategic partnership with Blade Urban Air Mobility ("Blade") designed to expand customer reach, increase booking op
Every FLYTE aircraft combines the Cirrus Vision Jet’s CAPS whole-aircraft parachute and Safe Return Emergency Autoland with onboard LifeVac life-saving equipment. Partnership reflects FLYTE’s safety-first philosophy, integrating advanced aviation technology with onboard medical emergency preparedness. "Safety isn’t one feature. It’s a system." From aircraft selection and pilot training to emergency automation and onboard medical equipment, safety is built into every layer of the FLYTE experience. FORT MILL, S.C., July 07, 2026 (GLOBE NEWSWIRE) -- Fly Flyte, Inc. ("Flyte"), the rapidly growing Regional Air Mobility subsidiary of Catheter Precision, Inc. (NYSE:VTAK), today announced a st
FORT MILL, S.C., July 02, 2026 (GLOBE NEWSWIRE) -- Flyte, a subsidiary of Catheter Precision, Inc. (NYSE:VTAK) ("VTAK" or the "Company"), today announced continued operational growth following the launch of its enhanced digital booking platform, www.flyflyte.com. During the first six months of 2026, Flyte acquired more than 1,000 new platform users, facilitated 118 flights across its growing network, and generated more than $1.0 million in revenue as demand continued to increase across multiple distribution channels. The Flyte platform allows customers to instantly price and book a Flyte Jet through a seamless digital experience, bringing a level of transparency and accessibility that ha
Clinical, Commercial and Regulatory Milestones Achieved in 2025 Establish a Strong Foundation in Life Sciences as Revenue Increases 95% Year Over Year Acquisition of Flyte and Strengthened Capital Position Unlock Multi-Segment Growth Strategy with Multiple Near-Term Catalysts FORT MILL, S.C., March 31, 2026 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (NYSE:VTAK) ("VTAK" or the "Company"), a U.S.-based innovative medical device company focused on electrophysiology products, today announced its financial results and operational update for the fourth quarter and full year ended December 31, 2025 as well as certain other business updates. 2025: Execution Across Clin
NEW YORK, March 10, 2026 (GLOBE NEWSWIRE) -- Creatd, Inc. (OTCQB:CRTDD) today announced that it has sold its remaining 80% equity stake in its subsidiary, Fly Flyte, Inc. ("Flyte"), to Catheter Precision, Inc. (NYSE:VTAK). Under the terms of the completed transaction, Creatd will receive approximately $6,000,000 in cash and nearly $6,000,000 in Convertible Preferred Stock of VTAK. The NYSE-approved transaction considerably strengthens Creatd's balance sheet. The sale is consistent with Creatd's strategy of developing turnkey operating solutions that prepare businesses for listing on the public markets while simultaneously retaining a minority interest in them. The transaction positions Cr
Strategic Partnership: Creatd expanded Fly Flyte's investor network by adding NYSE-listed VTAK as an investor in its subsidiary.Portfolio Expansion: Creatd continues advancing its portfolio strategy through multiple active acquisition discussions.Innovation in Aviation: Fly Flyte, Inc. is transforming regional aviation through accessibility, convenience, and technology-driven operations. NEW YORK, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Creatd, Inc. (OTCQB:CRTD) announced that Catheter Precision, Inc. (NYSE:VTAK) has acquired a 20% equity interest in Fly Flyte, Inc., its subsidiary, through a secondary purchase from an existing shareholder. The transaction aligns with Creatd's strategy of nurtu
FORT MILL, SC / ACCESSWIRE / January 7, 2025 / Catheter Precision, Inc. (NYSE:VTAK), a U.S.-based innovative medical device company focused on electrophysiology products, today announced that it has brought on board Philip Anderson, to take on the position of Chief Financial Officer. Margrit Thomassen, who has been our Interim Chief Financial Officer, will continue with the company in the role of Controller.David Jenkins, CEO of Catheter Precision, commented on the hire, "After some time of searching for the right fit, we are happy to have concluded our search with Phil Anderson joining the team. His background includes executive management across a variety of industries, managing hedge fund
FORT MILL, SC / ACCESSWIRE / January 22, 2024 / Catheter Precision, Inc. (NYSE:VTAK), (the Company) a pioneering U.S. based medical device company committed to enhancing the well-being of patients with cardiac arrhythmias, is pleased to declare its participation in the forthcoming Sequire Investor Summit 2024. The eagerly awaited event, slated for January 23-25, 2024, at the Condado Vanderbilt Hotel in San Juan, Puerto Rico, is poised to provide a spectrum of compelling opportunities for funds, companies, and investors.Puerto Rico has become a hub for family offices, funds, and affluent investors, thanks to its advantageous tax benefits. It stands out as one of the rare locations globally wh
SC 13G/A - Catheter Precision, Inc. (0001716621) (Subject)
SC 13G/A - Catheter Precision, Inc. (0001716621) (Subject)
SC 13D/A - Catheter Precision, Inc. (0001716621) (Subject)